“Comparison of Clinical Effectiveness of Folfirinox versus Gemcitabine on Quality of Life in Patients with Pancreatic Cancer Stage IV” (2017) Asian Journal of Pharmaceutics (AJP), 11(03). doi:10.22377/ajp.v11i03.1468.